FINWIRES · TerminalLIVE
FINWIRES

BriaCell Says Presenting Posters, Publication-only Abstracts at ASCO 2026

By

BriaCell Therapeutics (BCT.TO), down 6% in U.S. pre-market trading, is showcasing three clinical data poster presentations and three publication-only abstracts at the 2026 ASCO Annual Meeting, taking place May 29-June 2 in Chicago, the company said on Friday.

The presentations will include two poster presentations featuring data from BriaCell's ongoing Phase 3 study of Bria-IMT plus an immune checkpoint inhibitor, Bria-ABC, and one poster highlighting further analyses of Phase 2 data.

"Our positive clinical data across six presentations or abstracts at the ASCO 2026 Annual Meeting highlight the progress we are making in our clinical programs," said William Williams, BriaCell's chief executive. "These data reflect our commitment to advancing innovative therapeutic options for patients with cancer patients who need better treatments."

BriaCell shares were last seen down US$0.22, to US$3.50 in New York trading.

Related Articles

Mining & Metals

Earnings Flash (WOLF.V) Grey Wolf Animal Health Reports Q1 Revenue $8.8M, Up 10.5% YoY; Adjusted EBITDA Up 16.6%

$WOLF.V
Mining & Metals

Abcourt Mines Reports Wider Loss for Its Fiscal Third Quarter

Abcourt Mines (ABI.V) after trade on Thursday said its third-quarter loss widened year-over-year.The company's loss stood at $7.7 million, or $0.01 per share, in the period, compared with a loss of $5.5 million, or $0.01, a year ago.Revenue for the quarter ended March 31 was $7.9 million. Prior-year figures were not available.The company said during the quarter, it continued developing mining operations at Sleeping Giant. Expenses included preparing and rehabilitating tunnels for future production, maintaining facilities and equipment, and hiring staff."The development of the Sleeping Giant mine continues to progress towards commercial production. Several developments are underway and will continue in the coming months to access multiple work sites and increase production flexibility and pace," Chief Executive Pascal Hamelin said.Abcourt shares closed up $0.005 to $0.09 on the TSX Venture Exchange.

$ABI.V
Mining & Metals

Earnings Flash (MPH.V) Medicure Reports Q1 Total Net Revenue $7.9M Vs $5.4M a Year Ago; Net Loss $406,000 or $0.04 Per Share

$MPH.V